Twist Bioscience Corporation TWST Reportable Segment — Net loss, basic and diluted
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's reportable segment — net loss, basic and diluted.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's reportable segment — net loss, basic and diluted?
- Twist Bioscience Corporation (TWST) reported reportable segment — net loss, basic and diluted of -$44.02M in Q1 2026.
- How has Twist Bioscience Corporation's reportable segment — net loss, basic and diluted changed year-over-year?
- Twist Bioscience Corporation's reportable segment — net loss, basic and diluted decreased by 11.9% year-over-year, from -$39.33M to -$44.02M.
- What does reportable segment — net loss, basic and diluted mean?
- This represents the final bottom-line financial result for the reportable segment after all operating expenses, taxes, and non-operating items have been accounted for. A net loss indicates that the segment's costs and expenses exceeded its revenues during the period. Tracking this is critical for assessing the segment's path toward self-sustainability and profitability.